Beneficient (BENF) Convertible Debt (2024)
Beneficient's (BENF) quarterly Convertible Debt came in at $2.7 million in Q4 2024, up 39.46% quarter-over-quarter from $1.9 million in Q3 2024.
Powered by 
Analysis
Beneficient (BENF) Convertible Debt (2024) Analysis & Trends
Beneficient has disclosed Convertible Debt across 1 years of filings, most recently posting $2.7 million for Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 43.61 Bn | 43.61 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 26.51 Bn | 25.67 Bn | - |
| 3 | Royal Gold | 21.73 Bn | 21.55 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.78 Bn | 6.70 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.10 Bn | 1.91 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.40 Bn | 842.38 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Upbound | 1.07 Bn | 964.61 Mn | 594.84 Mn |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - |
| 10 | Beneficient | 2.67 Mn | -2.93 Mn | - |